Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
SBC Medical will participate in several upcoming investor conferences in May and June 2026
GlobeNewswire, Inc.
IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today...
MyHealth Haven Launches Health Navigator™ Platform to Help Americans Access Affordable Structured Medical Care
EIN Presswire
A New Model: Americans Can Now Access Transparently Priced Affordable Medical Care in Mexico With Structured Personal Support From Start To Finish DALLAS, TX, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- New cross-border healthcare...
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
GlobeNewswire, Inc.
Company announcement No. 18 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 21, 2026) Copenhagen, Denmark, May 26, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Army medical maintenance leaders meet to sharpen processes, support for Soldiers
DVIDS - Georgia
HILL AIR FORCE BASE, Utah — Medical maintenance leaders from U.S. Army Medical Logistics Command gathered April 29-30 in Utah to review their operations and find new ways to improve how they support the operational force.
Banner Health report shows Arizona research driving national medical innovation
GlobeNewswire, Inc.
Phoenix, May 26, 2026 (GLOBE NEWSWIRE) -- Banner Health's $80.5 million research enterprise delivered breakthrough treatments to Arizona patients in 2025 while advancing wide-ranging therapies toward FDA approval, according to the organization's...
Resolutions from Zealand Pharma's Extraordinary General Meeting 2026
GlobeNewswire, Inc.
Company announcement – No. 17 / 2026 Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 Copenhagen, Denmark, May 26, 2026 - Zealand Pharma A/S ("Zealand Pharma" or the “Company”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...
Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering
GlobeNewswire, Inc.
CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced the pricing of an underwritten public offering of...
The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference
GlobeNewswire, Inc.
CERRITOS, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Yale D. Podnos, MD, MPH, FACS, Chief Medical Officer,...
Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts
GlobeNewswire, Inc.
Vancouver, Canada, May 26, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second-generation,...
AiM Medical Robotics Announces Collaboration Agreement with Siemens Healthineers to Advance MRI-Guided Robotic Neurosurgery
GlobeNewswire, Inc.
Worcester, MA, May 26, 2026 (GLOBE NEWSWIRE) -- AiM Medical Robotics, a leading developer of advanced robotic systems for MRI-guided neurosurgery, today announced a collaboration agreement with Siemens Healthineers for the implementation of an...
RenovoRx Announces Promising Pharmacokinetic Data Using the TAMP™ Platform Presented at the 2026 ASCO Annual Meeting
GlobeNewswire, Inc.
Sub-Study from Ongoing Phase III TIGeR-PaC Clinical Trial Supports TAMP for Targeted Intra-Arterial Delivery of Gemcitabine, Demonstrating Potential to Increase Local Drug Potency and Reduce Systemic Exposure and Common Side Effects MOUNTAIN VIEW,...
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
GlobeNewswire, Inc.
Israel becomes the second jurisdiction and the first outside of the U.S. to grant marketing clearance for the LIBERTY System The AMAR regulatory approval will enable the Company to obtain a Free Sale Certificate to support submissions and...
Smart Packaging Market Forecast: $38.6 Billion by 2030 | RFID, Sensors & Pharma Innovations Boost Expansion
EIN Presswire
Smart Packaging Market Forecast: $38.6 Billion by 2030 | RFID, Sensors & Pharma Innovations Boost Expansion NEW CASTLE, DELAWARE , INDIA, May 26, 2026 /EINPresswire.com/ -- The global packaging industry is in the midst of a significant...
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
GlobeNewswire, Inc.
Novel, potent pan-viral inhibitors targeting the viral replication complex are under development for the treatment of hantavirus, bunyavirus and influenza Hantavirus and bunyavirus infections represent significant unmet medical needs, contribute...
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GlobeNewswire, Inc.
BOSTON, May 26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that...
Important Notice to Long-Term Shareholders of Molina Healthcare, Inc. (NYSE: MOH); MongoDB, Inc. (NASDAQ: MDB); New Era Energy & Digital, Inc. (NASDAQ: NUAI); and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Grabar Law Office is Investigating Claims…
GlobeNewswire, Inc.
PHILADELPHIA, May 26, 2026 (GLOBE NEWSWIRE) -- MOLINA HEALTHCARE, INC. (NYSE: MOH): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Molina Healthcare, Inc. (NYSE: MOH). The investigation concerns whether...
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
GlobeNewswire, Inc.
Enrollment is tracking ahead of schedule, allowing potential acceleration of key trial milestones Minimum enrollment to support interim analysis expected as soon as early July 2026 Randomized, double-blind, placebo-controlled trial is evaluating...
NRI Welcomes Dr. John Batsis as Medical Director of the Clinical Research Core
EIN Presswire
Dr. John Batsis joins the NRI as Medical Director of the Clinical Research Core, bringing expertise in aging, obesity and participant-centered research.
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting
GlobeNewswire, Inc.
Real-world analysis of three years of closed claims data from Symphony Health focused on the third year of the study (2023-2024), comprised of more than 261,000 U.S. adults with fibromyalgia Data underscore high comorbidity burden, multimodal...
Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers
GlobeNewswire, Inc.
Data affirms Corbus strategy of targeting tumor types with elevated Nectin-4 expression and clear unmet medical needs while providing an attractive commercial path forward Confirmed ORR of 42.9% observed in 2L oropharyngeal squamous cell carcinoma...
Sign up for:
Today in Medicine
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.